(Q73462123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

meta-analysis

0 references

title

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

lymphoblastic leukemia

1 reference

D O Harms

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G E Janka-Schaub

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

2234-2239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11187914%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401974

4 November 2019

exact match

0 references

cites work

[Acute lymphoblastic leukemia in childhood: the COALL studies]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

[The COALL-85 cooperative study for risk patients with acute lymphatic leukemia: initial results]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

[In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021

[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401974

7 January 2021